Health Care & Life Sciences » Pharmaceuticals | Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
45,259.50
45,941.30
46,293.40
46,996.90
-
-
Depreciation, Depletion & Amortization
14,624.50
13,754.00
11,987.30
11,195.70
-
-
Other Funds
1,168.60
970.50
4,334.30
5,931.40
-
-
Funds from Operations
58,715.40
60,665.80
53,946.40
52,261.20
50,158.00
-
Changes in Working Capital
22,297.90
36,946.10
17,718.90
32,773.20
-
-
Net Operating Cash Flow
36,417.50
23,719.80
36,227.50
19,488.00
-
-
Capital Expenditures
2,124.10
3,971.60
8,711.80
26,083.90
-
Sale of Fixed Assets & Businesses
-
556.90
715.00
17.40
-
Purchase/Sale of Investments
1,979.40
75.30
815.10
825.40
-
Net Investing Cash Flow
4,103.50
3,490.00
8,811.90
26,891.90
-
Issuance/Reduction of Debt, Net
26,029.50
27,316.80
27,539.00
8,377.50
-
Net Financing Cash Flow
26,029.50
27,316.80
27,539.00
8,377.50
-
Net Change in Cash
6,284.50
7,087.10
123.40
973.50
-
Free Cash Flow
34,293.40
19,748.20
27,515.70
6,595.90
-

About Gujarat Themis Biosyn

View Profile
Address
Themis House
Mumbai Maharashtra 400104
India
Employees -
Website http://www.gtbl.in
Updated 07/08/2019
Gujarat Themis Biosyn Ltd. is a pharmaceutical company, which engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.